Article Text

Download PDFPDF

206 Validation of NanoString® technologies for solid tumor clinical studies: robustness, precision and inter-site comparison
  1. Alexy Promonet,
  2. Ali-Réza Stroili,
  3. Xavier Pichon and
  4. Amanda Finan-Marchi
  1. Cerba Research, Montpellier, France


Background The evolution of bulk and spatial Omics technologies coincides with a need for novel biomarkers in clinical studies for diagnostics, prognostics, agnostics, and/or mechanisms of action. Cerba Research is dedicated to validating research-based technologies for use in global clinical studies.

Methods Cerba Research has developed internal workflows for bulk (nCounter) and spatial (GeoMx) RNA analysis on formalin fixed paraffin embedded (FFPE) tissues with NanoString platforms. The validation tests of robustness, precision, and inter-site are presented here.

Results nCounter (n=12) and GeoMx (n=16) workflows were successfully applied to a range of solid tumor FFPE tissue including lung, breast, skin, and colon showing robustness of the methods. A high correlation of inter- and intra-assay precision was also measured for RNA extraction (quantity and quality(DV200)) and nCounter assays with the PanCancer IO360 panel (R2≥0.97). Precision of the GeoMx whole transcriptome atlas assay with NGS readout showed an 88% repeatability correlation and 79% for reproducibility. Four non-small cell lung cancer samples were processed (FFPE curls, RNA extraction, nCounter PanCancer Pathway Panel) at both Cerba Research and an external sub-contracted lab. Inter-site analysis showed a correlation of R2=0.94.

Conclusions These results demonstrate the reliability of these methods at Cerba Research giving confidence to clients for use in clinical studies. Cerba Research is committed to expand these validations to maximize a bulk and spatial Omics offering.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.